Asthma programme in Finland: a community problem needs community solutions

Finland, like many other western countries, has experienced profound structural changes during the post-war period: urbanisation, increasing education, smaller family size, improved hygiene for food and household water, and prophylaxis and effective care of many potentially dangerous infectious diseases. Many of these factors have been associated with the increased risk for asthma and allergies1 which has also been found in Finland.2 In 1993 the Ministry of Social Affairs and Health in Finland recognised asthma as an important public health issue by appointing a working group to design a national programme for the prevention and alleviation of problems caused by asthma and for reduction of the relevant costs. The group decided to create an action programme emphasising guideline implementation and follow up, which are often neglected in consensus reports on asthma treatment. The 10 year programme was launched in 1994.3 The goals of prevention and treatment were stated as follows: (1) recovery of as many patients as possible with early asthma; (2) asthmatic patients should feel well and their ability for work and functional capacity should correspond with their age; (3) decline in the percentage of patients with severe and moderate asthma from the current 40% to 20%; (4) decrease in the number of bed days of asthmatic patients by 50% by the year 2000 (that is, to 50 000 a year); and (5) reduction in the annual treatment costs per patient by 50% as a result of more effective prevention and treatment of symptoms. The measures towards achieving the goals were as follows: (1) early diagnosis and active treatment; (2) guided self-management as the primary form of treatment; (3) decrease in respiratory irritants such as smoking and tobacco smoke; (4) implementation of rehabilitation on an outpatient basis combined with normal treatment, planned individually and timed appropriately; (5) increase …

[1]  A. Bauman,et al.  Limited (information only) patient education programs for adults with asthma. , 2002, The Cochrane database of systematic reviews.

[2]  G. Crompton,et al.  Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. , 2001, The European respiratory journal.

[3]  M. Daly,et al.  A susceptibility locus for asthma-related traits on chromosome 7 revealed by genome-wide scan in a founder population , 2001, Nature Genetics.

[4]  S. Salminen,et al.  Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial , 2001, The Lancet.

[5]  C. van Weel,et al.  Self management in asthma care , 2000, BMJ : British Medical Journal.

[6]  C. Pantin,et al.  Is the quality of asthma prescribing, as measured by the general practice ratio of corticosteroid to bronchodilator, associated with asthma morbidity? , 2000, Journal of clinical epidemiology.

[7]  T. Haahtela,et al.  Airway inflammation in patients with symptoms suggesting asthma but with normal lung function. , 2000, The European respiratory journal.

[8]  T. Klaukka,et al.  Corticosteroid therapy and need for hospital care in wheezing preschool children , 2000, European Journal of Clinical Pharmacology.

[9]  T. Haahtela,et al.  Detection and treatment of early asthma , 2000, Allergy.

[10]  J Bousquet,et al.  Asthma. From bronchoconstriction to airways inflammation and remodeling. , 2000, American journal of respiratory and critical care medicine.

[11]  R. Dahl,et al.  Nordic consensus report on asthma management , 2000 .

[12]  K. Chung,et al.  Delivering effective asthma care--how do we implement asthma guidelines? , 2000, The European respiratory journal.

[13]  L. Boulet,et al.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[14]  L. Boulet,et al.  Summary of recommendations from the Canadian Asthma Consensus Report, 1999 , 1999 .

[15]  P. Holt,et al.  Role of microbial burden in aetiology of allergy and asthma , 1999, The Lancet.

[16]  H. Sampson Allergic Factors Associated With the Development of Asthma andthe Influence of Cetirizine in a Double-Blind, Randomized,Placebo-Controlled Trial: First Results of ETAC , 1999, Pediatrics.

[17]  David W Rattner,et al.  Future directions in innovative minimally invasive surgery , 1999, The Lancet.

[18]  Prof. Ulrich Wahn Allergic factors associated with the development of asthma and the influence of cetirizine in a double‐blind, randomised, placebo‐controlled trial: First results of ETA® , 1998 .

[19]  E. Valovirta Capacity of specific immunotherapy in prevention of allergic asthma in children: the Preventive Allergy Treatment Study (PAT). , 1997, Journal of investigational allergology & clinical immunology.

[20]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[21]  F. Hargreave,et al.  Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. , 1996, American journal of respiratory and critical care medicine.

[22]  Tari Haahtela,et al.  Randomised comparison of guided self management and traditional treatment of asthma over one year , 1996, BMJ.

[23]  T. Haahtela,et al.  Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. , 1994, The New England journal of medicine.

[24]  J. Grimshaw,et al.  Achieving health gain through clinical guidelines II: Ensuring guidelines change medical practice. , 1994, Quality in health care : QHC.

[25]  T. Haahtela,et al.  A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. , 1992, The Journal of allergy and clinical immunology.

[26]  J. Denburg,et al.  Use of induced sputum cell counts to investigate airway inflammation in asthma. , 1992, Thorax.

[27]  T. Haahtela,et al.  Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. , 1991, The New England journal of medicine.

[28]  F Björkstén,et al.  Prevalence of asthma in Finnish young men. , 1990, BMJ.

[29]  T. Haahtela,et al.  Damage of the airway epithelium and bronchial reactivity in patients with asthma. , 1985, The American review of respiratory disease.

[30]  P. Puska,et al.  Smoking cessation advice from health professionals: process evaluation of a community-based program. , 1999, Patient education and counseling.

[31]  E. McCrum,et al.  General practice Randomised controlled trial of the READER method of critical appraisal in general practice , 1998 .

[32]  North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management in adults. , 1996, BMJ.

[33]  T. Haahtela,et al.  Asthma programme in Finland 1994-2004. Report of a Working Group. , 1996 .